Source Shorts
California Attorney General Sues Sutter Health for Anticompetitive Practices
Amy Y. Gu, Managing Editor March 30, 2018
See UFCW & Employers Benefit Trust v. Sutter Health case page. California’s attorney general announced today that his office has filed an antitrust and unfair competition lawsuit against Sutter Health. Attorney General Xavier Becerra said at a press conference that the state’s complaint follows a six-year statewide investigation that found the Northern California hospital giant engaged in anticompetitive conduct that drove up healthcare prices for patients and employers in the state. Specifically, the complaint alleges that Sutter engaged in “all-or-nothing” contracts with health insurers that restricted insurers from providing low-cost plan options …
Continue Reading Download PDF
Source Shorts: White House Releases Report on Drug Pricing
Katie Gudiksen, Senior Health Policy Researcher February 13, 2018
On Friday, February 9, 2018, the White House released a report from the Council of Economic Advisers (CEA) entitled “Reforming Biopharmaceutical Pricing at Home and Abroad”. The report identifies two seemingly conflicting goals of the current administration: 1) reducing domestic drug prices and 2) spurring economic investment in medical innovation. These goals appear to conflict since lower prices would likely mean lower profits for drug companies, resulting in lower investment in research and development. The report also accuses foreign governments of eroding global returns for investment in pharmaceuticals, stating: “nations …
Continue Reading Download PDF
Source Short: A Basic Understanding of What’s Really Driving Healthcare Costs
Amy Y. Gu, Managing Editor October 12, 2017
It’s common knowledge that the U.S. spends more than any other country on health care. In a series of blog posts, David Lansky, PhD of the Center for Health Journalism aims to give us a basic summary and understanding of the many factors contributing to the out of control healthcare spending. In part 1 of his blog post, Lansky explains why our healthcare spending is so high, and the five main culprits that push costs up. In part 2 of his blog post, Lansky outlines additional factors that should bring …
Continue Reading Download PDF
Source Shorts: Medicare Officially Kills Program to Pilot Pharmaceutical Payment Reform
Katie Gudiksen, Senior Health Policy Researcher October 4, 2017
The Centers for Medicaid and Medicare officially dropped any attempt to implement a pilot program that would change the way drugs were reimbursed under Medicare Part B. This pilot reform attempt has been on hold for more than a year, but CMS has now officially withdrawn it. How does Medicare Part B cover prescriptions? Medicare Part B only covers drugs that are administered in a doctor’s office or clinic, which are primarily intravenous and injectable drugs (the bulk of pharmaceuticals are covered under Medicare Part D and would not …
Continue Reading Download PDF
Pfizer files Groundbreaking Lawsuit against J&J Alleging Anticompetitive Practices
Katie Gudiksen, Senior Health Policy Researcher September 28, 2017
Pfizer filed a lawsuit on Wednesday, September 20, alleging Johnson &|Johnson (J&J) made “exclusionary contracts” with insurers regarding their drug Remicade. Remicade (infliximab) is biologic medication that must be administered via IV infusion. In contrast to most drugs that are chemically synthesized, biologic medications are large biological molecules or complex mixtures that are not easily duplicated. Remicade (infliximab) is a monoclonal antibody. As biologic medications cannot be exactly duplicated, the FDA process for approving biosimilars is similar but not identical to the Abbreviated New Drug Application (ANDA) process for small molecule generic drugs. …
Continue Reading Download PDF
Washington State AG files suit against Franciscan Health System
Katie Gudiksen, Senior Health Policy Researcher September 12, 2017
The Washington State AG filed suit to thwart and unwind Franciscan Health Systems (FHS) most recent expansion attempts alleging violation of both state and federal antitrust laws. In a rarely seen antitrust enforcement action, the Washington AG’s office is asking the court to unwind FHS’ 2016 acquisition of WestSound Orthopaedics for violation of Section 7 of the Clayton Act and the Washington Consumer Protection Act and several affiliation agreements from 2016 between The Doctors Clinic and FHS for violation of Section 1 of the Sherman Act and the Washington Consumer …
Continue Reading Download PDF
Class Certification Granted in UFCW & Employers Benefit Trust v. Sutter Health
Anna Zaret, Managing Editor August 22, 2017
See UFCW & Employers Benefit Trust v. Sutter Health case page. We have previously blogged about a key California case brought by self-funded payers against Sutter Health, the dominant health care provider in Northern California, UFCW &|Employers Benefit Trust v. Sutter Health. Last week, the plaintiffs overcame a major hurdle in litigation when the court granted class certification. To remind you, UEBT filed this class action on behalf of itself and other self-funded payers. The defendants in the case are Sutter and the group referred to as “Network Vendors,” which are the …
Continue Reading Download PDF
The Source Executive Editor Jaime King on ‘The Week in Health Law’ Podcast
Anna Zaret, Managing Editor and Katie Beyer June 22, 2017
The most recent episode of The Week in Health Law podcast features The Source’s own Professor Jaime King! The episode, titled “Competition, Coordination, and Complexity,” covers price transparency issues, provider competition and consolidation, and ERISA preemption. In the discussion, Professor King explains how greater price transparency will help promote competition in some ways, but it will not solve all problems. The first model of price transparency directed at consumer rates only influences consumers who purchase “shop-able services” (services that patients assume are substitutable for one another, such as lab tests). Professor …
Continue Reading Download PDF
How People Find and Use Price Information: Public Agenda’s Price Transparency Survey
Anna Zaret, Managing Editor April 27, 2017
A recently published Public Agenda report by David Schleifer, Rebecca Silliman, and Chloe Rinehart provides a wealth of new information about how Americans are seeking out and using information about health care prices. One key finding from the report is that while Americans do seek out information about how much their health care will cost, they still need more help accessing price information, in particular provider price comparisons. The report analyzes information found through a national survey and state surveys of residents in Florida, New York, New Hampshire, and Texas. …
Continue Reading Download PDF
Update: Carolinas Healthcare Argues DOJ Fails to Allege Actual Competitive Harm in Anti-Steering Suit
Anna Zaret, Managing Editor September 24, 2016
September 2016 Update: We previously blogged about the suit filed in June by the Department of Justice and the North Carolina Attorney General against Carolinas Healthcare System (“CHS”). The case involves a Sherman Act Section 1 challenge to anti-steering provisions in CHS’ contracts with insurers. In August, CHS moved for judgment on the pleadings. CHS filed its reply brief in support of the motion on Wednesday. In its brief, CHS argues that the DOJ complaint is insufficient as a matter of law because it fails to show that the anti-steering …
Continue Reading Download PDF